Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 2Lymphoma 2Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Hepatocellular 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Rituximab 49Cyclophosphamide 28venetoclax 24Bendamustine Hydrochloride 24obinutuzumab 22ibrutinib 21Chlorambucil 20fludarabine 16fludarabine phosphate 15idelalisib 13acalabrutinib 11pirtobrutinib 7ofatumumab 7zanubrutinib 5Vincristine 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Cyclosporine 5Radiotherapy 4Prednisone 4Doxorubicin 4duvelisib 3Whole-Body Irradiation 3Specimen Handling 3Methotrexate 3Lenalidomide 3Filgrastim 3Epoetin Alfa 3Cyclosporins 3Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Lymphocytic, Chronic, B-Cell × Steroids × Clear all
NCT00004112 2024-09-23

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

University of Nebraska

Phase 3 Completed
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡